Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1958 Feb;21(1):58–62. doi: 10.1136/jnnp.21.1.58

EPINEPHRINE METABOLITES AND PIGMENTATION IN THE CENTRAL NERVOUS SYSTEM IN A CASE OF PHENYLPYRUVIC OLIGOPHRENIA

J H Fellman 1,*
PMCID: PMC497295  PMID: 13514500

Full text

PDF
58

Images in this article

59Image
on p.59
61Image
on p.61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG M. D., ROBINSON K. S. On the excretion of indole derivatives in phenylketonuria. Arch Biochem Biophys. 1954 Sep;52(1):287–288. doi: 10.1016/0003-9861(54)90115-0. [DOI] [PubMed] [Google Scholar]
  2. ARMSTRONG M. D., TYLER F. H. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria. J Clin Invest. 1955 Apr;34(4):565–580. doi: 10.1172/JCI103105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOSCOTT R. J., BICKEL H. Detection of some new abnormal metabolites in the urine of phenylketonuria. Scand J Clin Lab Invest. 1953;5(4):380–382. doi: 10.3109/00365515309094216. [DOI] [PubMed] [Google Scholar]
  4. CORSELLIS J. A. The pathological report of a case of phenylpyruvic oligophrenia. J Neurol Neurosurg Psychiatry. 1953 Aug;16(3):139–143. doi: 10.1136/jnnp.16.3.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DANCIS J., BALIS M. E. A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia. Pediatrics. 1955 Jan;15(1):63–66. [PubMed] [Google Scholar]
  6. FELLMAN J. H. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc Soc Exp Biol Med. 1956 Dec;93(3):413–414. doi: 10.3181/00379727-93-22773. [DOI] [PubMed] [Google Scholar]
  7. FITZPATRICK T. B., MIYAMOTO M. Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria. Nature. 1957 Jan 26;179(4552):199–200. doi: 10.1038/179199b0. [DOI] [PubMed] [Google Scholar]
  8. JERVIS G. A. Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system. Proc Soc Exp Biol Med. 1953 Mar;82(3):514–515. [PubMed] [Google Scholar]
  9. KUKITA A., FITZPATRICK T. B. Demonstration of tyrosinase in melanocytes of the human hair matrix by autoradiography. Science. 1955 Jun 24;121(3156):893–894. [PubMed] [Google Scholar]
  10. LUND A. Fluorimetric determination of adrenaline in blood; a new sensitive and specific method. Acta Pharmacol Toxicol (Copenh) 1949 Oct;5(3):231–247. doi: 10.1111/j.1600-0773.1949.tb03389.x. [DOI] [PubMed] [Google Scholar]
  11. SHEPHERD D. M., WEST G. B. Noradrenaline and the suprarenal medulla. Br J Pharmacol Chemother. 1951 Dec;6(4):665–674. doi: 10.1111/j.1476-5381.1951.tb00678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WEIL-MALHERBE H. The concentration of adrenaline in human plasma and its relation to mental activity. J Ment Sci. 1955 Oct;101(425):733–755. doi: 10.1192/bjp.101.425.733. [DOI] [PubMed] [Google Scholar]
  13. WOOLF L. I. Excretion of conjugated phenylacetic acid in phenylketonuria. Biochem J. 1951 Jun;49(1):ix–x. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES